Quick Answer
AEON Biopharma, Inc. reported Shares Outstanding of 12.11 million shares for fiscal year 2025.
AEON Biopharma, Inc. Shares Outstanding — Annual History
| Fiscal Year | Shares Outstanding | YoY Change |
|---|---|---|
| 2025 | 12.11M | +2079.2% |
| 2024 | 555,511 | +7.6% |
| 2023 | 516,404 | -99.6% |
| 2022 | 138.83M | — |
Quarterly Shares Outstanding
| Quarter Ending | Shares Outstanding | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | 11.64M | -70.6% | +0.9% |
| June 30, 2025 | 11.54M | -70.5% | +9.5% |
| March 31, 2025 | 10.54M | -72.4% | +1797.1% |
| December 31, 2024 | 555,511 | -98.5% | -98.6% |
| September 30, 2024 | 39.59M | +6.5% | +1.2% |
| June 30, 2024 | 39.12M | — | +2.6% |
| March 31, 2024 | 38.12M | — | +2.6% |
| December 31, 2023 | 37.16M | -73.2% | +0.0% |
- AEON Biopharma, Inc. showed an increase of +2079.2% in Shares Outstanding compared to the prior fiscal year.
- Over the 2022–2025 period, AEON Biopharma, Inc.’s shares outstanding has declined by 91.3% (from 138.83 million shares to 12.11 million shares).
- The most recent figure is from AEON Biopharma, Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 30, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: